Skip to main content
CDC Website

Hepatitis B Vaccine Talking Points

This fact sheet presents key talking points emphasizing the critical importance of administering the hepatitis B vaccine birth dose to newborns. 

Newly Reported Chronic Hepatitis C Among Adults — Alaska, 2016–2023

This webpage presents data on newly reported chronic hepatitis C cases in Alaska from 2016 to 2023. It underscores the importance of continued hepatitis C surveillance to guide targeted testing and treatment efforts toward disease elimination.

Hepatitis C and Your Liver Get Tested. Get Cured!

This booklet provides comprehensive information on hepatitis C, detailing its impact on liver health, modes of transmission, symptoms, and the importance of testing and treatment. The booklet outlines the progression from acute to chronic infection, potential liver complications, and available diagnostic tests. 

Hamilton Community Health Network

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Medicare Accepted
  • Sliding Scale

  • Chlamydia Test
  • Conventional HIV Test
  • Gonorrhea Test
  • Hepatitis C Test
  • Herpes Test
  • Syphilis Test

  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Adult Hepatitis B Vaccine
  • Family Planning
  • Hepatitis A Vaccine
  • Human Papillomavirus Vaccine (HPV)
  • STI Treatment

Integrating Management of Hepatitis C Infection into Primary Care: The Key to Hepatitis C Elimination Efforts

This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.

Hamilton Community Health Network

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Medicare Accepted
  • Sliding Scale

  • Chlamydia Test
  • Conventional HIV Test
  • Gonorrhea Test
  • Hepatitis C Test
  • Herpes Test
  • Syphilis Test

  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Adult Hepatitis B Vaccine
  • Family Planning
  • Hepatitis A Vaccine
  • Human Papillomavirus Vaccine (HPV)
  • STI Treatment
  • Substance Abuse Treatment

Hamilton Community Health Network

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Medicare Accepted
  • Sliding Scale

  • Chlamydia Test
  • Conventional HIV Test
  • Gonorrhea Test
  • Hepatitis C Test
  • Herpes Test
  • Syphilis Test

  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Adult Hepatitis B Vaccine
  • Family Planning
  • Hepatitis A Vaccine
  • Human Papillomavirus Vaccine (HPV)
  • STI Treatment

Terros Health

Contact organization for eligibility

Free Services Available

  • Free HIV Test
  • Free Hepatitis C Test
  • Free STI Test

Payment and Low Cost Options

  • No Fee

  • Chlamydia Test
  • Gonorrhea Test
  • Hepatitis C Test
  • Rapid HIV Test
  • Syphilis Test

  • Condom Distribution
  • HIV Test Counseling
  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Pre-Exposure Prophylaxis (PrEP)

  • PrEP Navigation
  • Ryan White Services

Clinical Course of Autoimmune Hepatitis in Hispanic and African American Patients: A Retrospective Study at a South Bronx Hospital

This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.

Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers

This journal compares the effectiveness of Heplisav-B and standard hepatitis B vaccines as boosters for healthcare workers with low immunity to hepatitis B, measured by anti-HBs antibody levels. Results show that Heplisav-B offers a significantly higher seropositivity rate (99.4%) compared to the standard vaccine (92.7%).